Matthew Hawryluk
Director/Board Member bij PREDICTIVE ONCOLOGY INC.
Vermogen: 761 476 $ op 31-03-2024
Profiel
Matthew J.
Hawryluk is an Independent Director at Predictive Oncology, Inc. and the Chief Business Officer & Executive Vice President at Gritstone bio, Inc. He was previously the Vice President-Corporate & Business Development at Foundation Medicine, Inc. Hawryluk received his undergraduate degree from the University of Notre Dame, his MBA from the Tepper School of Business, and his doctorate from the University of Pittsburgh School of Medicine.
Bekende belangen in openbare bedrijven
Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
---|---|---|---|---|
GRITSTONE BIO, INC.
0.29% | 01-02-2024 | 286 880 ( 0.29% ) | 737 282 $ | 31-03-2024 |
PREDICTIVE ONCOLOGY INC
0.23% | 05-04-2024 | 9 488 ( 0.23% ) | 24 194 $ | 31-03-2024 |
Actieve functies van Matthew Hawryluk
Bedrijven | Functie | Begin |
---|---|---|
GRITSTONE BIO, INC. | Corporate Officer/Principal | 01-11-2015 |
PREDICTIVE ONCOLOGY INC. | Director/Board Member | 29-11-2022 |
Eerdere bekende functies van Matthew Hawryluk
Bedrijven | Functie | Einde |
---|---|---|
FOUNDATION MEDICINE INC | Corporate Officer/Principal | - |
Opleiding van Matthew Hawryluk
University of Notre Dame | Undergraduate Degree |
Tepper School of Business | Masters Business Admin |
University of Pittsburgh School of Medicine | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 2 |
---|---|
PREDICTIVE ONCOLOGY INC. | Health Technology |
GRITSTONE BIO, INC. | Health Technology |
Bedrijven in privébezit | 1 |
---|---|
Foundation Medicine, Inc.
Foundation Medicine, Inc. Medical/Nursing ServicesHealth Services Foundation Medicine, Inc. is a molecular information company, which engages in the provision of information on clinical treatment decisions for patients with cancer. The company was founded on January 10, 2010 and is headquartered in Cambridge, MA. | Health Services |